The Association of Corticosteroid Therapy With Mortality and Length of Stay Among Children With Septic Shock: A Retrospective Cohort Study
- PMID: 36741650
- PMCID: PMC9891713
- DOI: 10.7759/cureus.33267
The Association of Corticosteroid Therapy With Mortality and Length of Stay Among Children With Septic Shock: A Retrospective Cohort Study
Abstract
Introduction Septic shock remains a leading cause of mortality in pediatric patients. Corticosteroids have been used in the management of sepsis and septic shock, but there is conflicting evidence on the potential benefit of corticosteroid therapy. This study assessed the risk of mortality and length of stay in the pediatric intensive care unit (PICU) among pediatric patients admitted with a septic shock diagnosis. Method A retrospective cohort study was conducted among pediatric patients (up to 14 years old) admitted with a septic shock diagnosis to the PICU of King Abdullah Specialist Children's Hospital in Riyadh from January 2016 to December 2021. The clinical outcomes of patients receiving corticosteroid therapy were compared to those of control patients who were not given corticosteroids. Electronic medical records provided clinical data, severity scores, and the management given for each patient. The patients were followed up from the date of sepsis diagnosis to hospital discharge. Proportional hazard ratios (HRs) were calculated to compare the risk of mortality, length of PICU stay, and length of hospital stay. Results A total of 182 pediatric patients were included in the study, and 86 (47%) received corticosteroid therapy. The median age of the study population was 15 months (interquartile range [IQR]: 2-72 months). Compared to the controls, the patients who received corticosteroids had a higher total Sequential Organ Failure Assessment (SOFA) score (mean±SD: 5.5±3 vs. 7.1±3.3, respectively; p <0.01) and required more ventilation support (72% vs. 28%, respectively) and the use of inotropes and vasopressors (74% vs. 34% and 32% vs. 6%, respectively). In-hospital mortality did not significantly differ between the groups (adjusted HR: 2.66; 95% confidence interval [CI]: 0.66-10.28). Those patients who received corticosteroids had 42% less risk of staying in the PICU for over six days than those not receiving steroids (HR: 0.35; 95% CI: 0.13-0.98) Conclusion After adjusting for baseline characteristics, severity scores, and medical intervention, no association was found between receiving corticosteroids and mortality (p=0.492). Furthermore, patients who received corticosteroids had less risk of a prolonged stay in the PICU than those who did not.
Keywords: corticosteroids; peditric sepsis; saudi arabia; sepsis; septic shock; severe sepsis.
Copyright © 2023, Alkhalaf et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Epidemiology of pediatric sepsis in the pediatric intensive care unit of king Abdulaziz Medical City, Jeddah, Saudi Arabia.BMC Pediatr. 2021 May 7;21(1):222. doi: 10.1186/s12887-021-02686-0. BMC Pediatr. 2021. PMID: 33962589 Free PMC article.
-
Sequential Organ Failure Assessment Score As a Predictor of Outcome in Sepsis in Pediatric Intensive Care Unit.J Pediatr Intensive Care. 2021 Jun;10(2):110-117. doi: 10.1055/s-0040-1714705. Epub 2020 Jul 30. J Pediatr Intensive Care. 2021. PMID: 33884211 Free PMC article.
-
Association of Antibiotics Administration Timing With Mortality in Children With Sepsis in a Tertiary Care Hospital of a Developing Country.Front Pediatr. 2020 Sep 9;8:566. doi: 10.3389/fped.2020.00566. eCollection 2020. Front Pediatr. 2020. PMID: 33014945 Free PMC article.
-
Association of Corticosteroid Treatment With Outcomes in Adult Patients With Sepsis: A Systematic Review and Meta-analysis.JAMA Intern Med. 2019 Feb 1;179(2):213-223. doi: 10.1001/jamainternmed.2018.5849. JAMA Intern Med. 2019. PMID: 30575845 Free PMC article.
-
Controversies in Corticosteroid use for Sepsis.J Emerg Med. 2017 Nov;53(5):653-661. doi: 10.1016/j.jemermed.2017.05.024. Epub 2017 Sep 12. J Emerg Med. 2017. PMID: 28916121 Review.
Cited by
-
Corticosteroids in Pediatric Septic Shock: A Narrative Review.J Pers Med. 2024 Dec 17;14(12):1155. doi: 10.3390/jpm14121155. J Pers Med. 2024. PMID: 39728068 Free PMC article. Review.
-
Immunomodulation in Pediatric Sepsis: A Narrative Review.J Clin Med. 2025 Apr 25;14(9):2983. doi: 10.3390/jcm14092983. J Clin Med. 2025. PMID: 40364014 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention: What is sepsis? [ Dec; 2022 ];https://www.cdc.gov/sepsis/what-is-sepsis.html 2022 3
-
- Andre Kalil M[.1. Septic shock treatment and management. [ Dec; 2022 ]. 2020. https://emedicine.medscape.com/article/168402-treatment https://emedicine.medscape.com/article/168402-treatment
-
- Sepsis. [ Dec; 2022 ];https://www.amboss.com/us/knowledge/Sepsis/ 2022 3
LinkOut - more resources
Full Text Sources